SolGel Technologies Ltd. (SLGL) Reports Q3 Loss, Misses Revenue Estimates

Published on 26 Mar 2023 on Zacks via Yahoo Finance

SolGel Technologies Ltd. (SLGL) Reports Q3 Loss, Misses Revenue Estimates

SolGel Technologies Ltd. (SLGL) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -114.29%. A quarter ago, it was expected that this company would post a loss of $0.10 per share when it actually produced a loss of $0.01, delivering a surprise of 90%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Read the rest of the article

NASDAQ.FIXX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Why Alkermes spun out an oncology company, whose shares have plummeted - Boston Business Journal

A year after it first floated the idea, Alkermes plc has broken out its cancer unit into a separa...

The Business Journals 17 Nov 2023

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13% By Investing.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%

Investing.com 17 Nov 2023

Gold Gains 1%; Williams-Sonoma Posts Upbeat Earnings - Homology Medicines (NASDAQ:FIXX), Children's...

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 100 poi...

Benzinga 16 Nov 2023

Big Pharma-backed startup to go public by merging with gutted Homology - Boston Business Journal

A three-year-old biotech backed by the venture arms of Sanofi ADR and Bristol Myers Squibb is goi...

The Business Journals 16 Nov 2023

12 Best Nano Cap Stocks To Buy Now

In this piece, we will take a look at the 12 best nano cap stocks to buy now. If you want to skip...

Insider Monkey via Yahoo Finance 6 Jul 2023

SolGel Technologies Ltd. (SLGL) Reports Q3 Loss, Misses Revenue Estimates

SolGel Technologies Ltd. (SLGL) came out with a quarterly loss of $0.15 per share versus the Zack...

Zacks via Yahoo Finance 26 Mar 2023

Homology Medicines (NASDAQ:FIXX) shareholders have endured a 90% loss from investing in the stock...

As an investor, mistakes are inevitable. But really big losses can really drag down an overall po...

Simply Wall St. via Yahoo Finance 24 Feb 2023

Homology Medicines Provides Update From Gene Therapy Trials

Homology Medicines Inc (NASDAQ: FIXX) expects to provide initial data from the pheEDIT trial of H...

Benzinga via Yahoo Finance 5 Jan 2023

Homology Medicines (FIXX) Reports Q3 Loss, Misses Revenue Estimates

Homology Medicines (FIXX) came out with a quarterly loss of $0.59 per share versus the Zacks Cons...

Zacks via Yahoo Finance 10 Nov 2022

The Petri Dish: Homology gets new CEO amid shakeup; two Boston firms join 'pandemic readiness' lobby

Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of health care...

American City Business Journals 8 Sep 2022

News

SolGel Technologies Ltd. (SLGL) Reports Q3 Loss, Misses Revenue Estimates

NASDAQ.FIXX price evolution

Want to become a better investor?